Opsis Therapeutics

Biotechnology Research • Madison, Wisconsin, United States • 1-10 Employees

Company overview

Headquarters	525 Science Dr, Madison, WI 53717, US
Phone number	+16083105100
Website	opsistx.com
NAICS	541714
SIC	873
Employees	1-10
Socials

Key Contact at Opsis Therapeutics

Rebecca Selzer

President & CEO

About Opsis Therapeutics

Opsis Therapeutics is a company focused on advancing the pipeline of cell replacement therapies targeting ocular diseases. Leveraging innovations in induced pluripotent cell (iPSC) generation, retinal cell differentiation, and functional biomaterials, Opsis Therapeutics is developing cell therapies for patients with dry age-related macular degeneration (AMD), inherited macular degenerations (IMDs) and inherited retinal diseases (IRDs). Founded in 2016, Opsis Therapeutics is a joint venture of FUJIFILM Cellular Dynamics and David Gamm, M.D., Ph.D., and is headquartered in Madison, Wisconsin.

Opsis Therapeutics revenue & valuation

Annual revenue	$342,220
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$1,100,000
Total funding	No funding

Employees by Management Level

Total employees: 1-10

Seniority

Employees

C-Suite

Employees by Department

Opsis Therapeutics has 1 employees across 1 departments.

Departments

Number of employees

Funding Data

Opsis Therapeutics has never raised funding before.